04.26.24 -- Five Key Attributes For Biotech Growth

In 2021 on Episode 13, Vor Bio’s President and CEO, Dr. Robert Ang shared data about the company’s lead eHSC product candidate. Dr. Ang is back to talk to Cell & Gene: The Podcast about how Vor has treated 8 patients demonstrating clinical proof of concept and is also in the clinic with a CAR-T that could be used in combination with shielded stem cell transplants. Listen now!

Utilizing OTS devices for drug delivery can offer significant advantages to development programs in timeline and risk mitigation. Understand the design control responsibilities when using OTS devices.

Depth of management typically is less about ensuring your trial progresses smoothly and more about hiding the CRO’s deficiencies or appeasing its own stakeholders.

In a recent webinar, pharmaceutical company Chiesi and CRO CROMSOURCE shared best practices from their decades-long partnership integral to ensuring inspection-ready TMFs.

Review the critical parameters for scalable production during upstream and downstream process development, with details on achieving scalable transfection in adherent and suspension platforms.

Enteric polymer coatings play a crucial role in oral drug formulations, protecting the API from harsh gastric conditions and enabling targeted drug delivery with optimized release based on location.

Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.

Gain insights from the founder and CEO of Jaguar Health Lisa Conte on building a successful life sciences organization through innovation.

Middlesex County, NJ, offers life sciences organizations a deep talent pool, an extensive R&D presence, and dedicated backing by local government investment.